We anticipate a high level of demand for our products, as they will allow labs to save money, time and
We anticipate a high level of demand for our products, as they will allow labs to save money, time and
Murrieta Genomics was recently named as a “company to watch” by The Healthcare Insights, a medical publication that discusses developments
Murrieta Genomics has announced that its wholly owned subsidiary, SimplSeq Inc., has filed a new patent application for simplified sample
Murrieta Genomics has partnered with Life Science Nation (LSN) and the RESI (Redefining Early Stage Investments) Conference to offer startup
Murrieta Genomics, LLC, the Southern California genomic sequencing business incubator, will see its first incubator company debut at one of